Skip to main content

COLLAGENASE SANTYL

Generic: COLLAGENASE SANTYL

Verified·Apr 23, 2026
Manufacturer
Smith and Nephew
NDC
50484-010
RxCUI
309509
Route
TOPICAL
ICD-10 indication
L89.909

Affordability Check

How much will you actually pay for COLLAGENASE SANTYL?

In 30 seconds, see every legitimate way to afford COLLAGENASE SANTYL — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About COLLAGENASE SANTYL

What is this medication?

Collagenase Santyl is a prescription enzymatic debriding ointment primarily used for the treatment of chronic skin ulcers and severe burns. Its main purpose is to remove necrotic, or dead, tissue from the site of a wound, a process known as debridement. Removing this damaged material is essential because it allows the wound to begin the natural healing process and prevents the accumulation of waste that could hinder recovery.

This medication contains a specific enzyme that works by breaking down the collagen strands that hold dead tissue to the wound bed. Because the enzyme is selective, it targets the necrotic tissue while leaving healthy, viable tissue intact. It is frequently prescribed for individuals suffering from pressure sores, diabetic ulcers, or venous stasis ulcers to help maintain a clean environment for new skin to grow.

Copay & patient assistance

  • Patient Copay Amount: $50
  • Maximum Annual Benefit Limit: $1,000 per year (Up to $250 per fill for a maximum of six fills)
  • Core Eligibility Restrictions: Not valid for patients enrolled in government-funded healthcare programs including Medicare (including Part D and Medicare Advantage), Medicaid, TRICARE, CHAMPUS, or the Puerto Rico Government Health Insurance Plan; must be a resident of the U.S.; not valid where prohibited by law.
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for COLLAGENASE SANTYL. Official source: DailyMed (NLM) · Label effective May 17, 2019

Indications and usage
INDICATIONS AND USAGE Collagenase Santyl ◊ Ointment is indicated for debriding chronic dermal ulcers 2, 3, 4, 5, 6, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 and severely burned areas. 3, 4, 5, 7, 16, 19, 20, 21
Dosage and administration
DOSAGE AND ADMINISTRATION Collagenase Santyl ◊ Ointment should be applied once daily (or more frequently if the dressing becomes soiled, as from incontinence). When clinically indicated, crosshatching thick eschar with a #10 blade allows Collagenase Santyl ◊ Ointment more surface contact with necrotic debris. It is also desirable to remove, with forceps and scissors, as much loosened detritus as can be done readily. Use Collagenase Santyl ◊ Ointment in the following manner: 1 - Prior to application the wound should be cleansed of debris and digested material by gently rubbing with a gauze pad saturated with normal saline solution, or with the desired cleansing agent compatible with Collagenase Santyl ◊ Ointment (See PRECAUTIONS ), followed by a normal saline solution rinse. 2 - Whenever infection is present, it is desirable to use an appropriate topical antibiotic powder. The antibiotic should be applied to the wound prior to the application of Collagenase Santyl ◊ Ointment. Should the infection not respond, therapy with Collagenase Santyl ◊ Ointment should be discontinued until remission of the infection. 3 - Collagenase Santyl ◊ Ointment may be applied directly to the wound or to a sterile gauze pad which is then applied to the wound and properly secured. 4 - Use of Collagenase Santyl ◊ Ointment should be terminated when debridement of necrotic tissue is complete and granulation tissue is well established.
Contraindications
CONTRAINDICATIONS Collagenase Santyl ◊ Ointment is contraindicated in patients who have shown local or systemic hypersensitivity to collagenase.
Adverse reactions
ADVERSE REACTIONS No allergic sensitivity or toxic reactions have been noted in clinical use when used as directed. However, one case of systemic manifestations of hypersensitivity to collagenase in a patient treated for more than one year with a combination of collagenase and cortisone has been reported.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How COLLAGENASE SANTYL appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

81%

4,453 of 5,509 plans

Most common tier

Tier 4

On 58% of covering formularies

Prior authorization required

28%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)58
18%
Tier 2 (generic)2
1%
Tier 3 (preferred brand)74
23%
Tier 4 (non-preferred brand)187
58%

Step therapy: 0% of formularies

Quantity limits: 88% of formularies

Coverage breadth: 321 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.